Wells Fargo Downgrades Quest Diagnostics To Underperform

Analysts at Wells Fargo downgraded Quest Diagnostics Inc. DGX from Market Perform to Underperform. Quest Diagnostics shares have gained 35.41% over the past 52 weeks, while the S&P 500 index has surged 13.39% in the same period. Quest Diagnostics' shares rose 0.74% to close at $71.09 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsWells Fargo
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!